132 related articles for article (PubMed ID: 2320285)
1. [Clinical aspects of respiratory pathology in scleroderma. Case reports].
Galietti F; Giorgis GE; Ardizzi A; Oliaro A; Zampollo M; Bernardi V; Miravalle C
Minerva Med; 1990 Mar; 81(3):181-4. PubMed ID: 2320285
[TBL] [Abstract][Full Text] [Related]
2. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
3. [Collageno-vascular diseases and interstitial pulmonary fibrosis. An analysis of diagnostic tests].
Baldi S; Rapellino M; Libertucci D; Obert R; Scappaticci E; Coni F; Revello F; Oliaro A; Botto-Micca F
Minerva Med; 1987 Sep; 78(17):1277-80. PubMed ID: 3670681
[TBL] [Abstract][Full Text] [Related]
4. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
[TBL] [Abstract][Full Text] [Related]
6. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
[TBL] [Abstract][Full Text] [Related]
7. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
[TBL] [Abstract][Full Text] [Related]
8. Assessments of pulmonary involvement in patients with systemic sclerosis.
Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
[TBL] [Abstract][Full Text] [Related]
10. Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
Sahhar J; Littlejohn G; Conron M
Intern Med J; 2004 Nov; 34(11):626-38. PubMed ID: 15546457
[TBL] [Abstract][Full Text] [Related]
11. Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis.
Komócsi A; Kumánovics G; Zibotics H; Czirják L
Rheumatol Int; 2001 Apr; 20(3):113-8. PubMed ID: 11354558
[TBL] [Abstract][Full Text] [Related]
12. Preliminary report: the origin of lavage neutrophils in fibrosing alveolitis associated with systemic sclerosis.
Reich JM
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Sep; 14(2):189-90. PubMed ID: 9306513
[No Abstract] [Full Text] [Related]
13. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
14. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
Witt C; Apostoloff E; Müller GM; Buchali K; Hiepe F; Brenke A; Romberg B; Winsel K
Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
[TBL] [Abstract][Full Text] [Related]
15. Bronchiolitis obliterans organizing pneumonia and scleroderma.
Bridges AJ; Hsu KC; Dias-Arias AA; Chechani V
J Rheumatol; 1992 Jul; 19(7):1136-40. PubMed ID: 1512774
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
[TBL] [Abstract][Full Text] [Related]
17. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease.
Kumánovics G; Zibotics H; Juhász E; Komócsi A; Czirják L
Clin Exp Rheumatol; 2001; 19(5):551-9. PubMed ID: 11579714
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic bronchoalveolar lavage in assessing the efficacy of the treatment of idiopathic fibrosing alveolitis].
Gerasin VA; Zhuravlev AV; Novikova LN; Palamarchuk GF
Ter Arkh; 1988; 60(12):63-6. PubMed ID: 3247657
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary involvement in sclerodermia].
Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
[TBL] [Abstract][Full Text] [Related]
20. [Study of high-resolution thoracic computerized tomography and bronchoalveolar lavage in 36 patients presenting with systemic disease and a normal thoracic radiography].
Dansin E; Wallaert B; Rémy-Jardin M; Perez T; Hatron PY; Rémy J; Tonnel AB
Rev Mal Respir; 1991; 8(6):551-8. PubMed ID: 1775714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
